https://www.selleckchem.com/products/mf-438.html
One of the patients who presented with severe hyperglycemia without DKA was started with NPH insulin, which later shifted to metformin. Good glycemic control was obtained with metformin, while the DTG-based ART regimen was continued. Hyperglycemia is a potential and noticed side effect of the DTG-based ART regimen. Baseline and periodic monitoring of plasma glucose might be required in ART regimens containing dolutegravir. Hyperglycemia is a potential and noticed side effect of the DTG-based ART regimen. Baseline and periodic monitoring
Beğen
Yorum Yap
Paylaş
